Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Rupatadine EP Impurity A
Rupatadine EP Impurity A
  • Rupatadine EP Impurity A
  • Rupatadine EP Impurity A
  • Rupatadine EP Impurity A
  • Rupatadine EP Impurity A
  • Rupatadine EP Impurity A

Rupatadine EP Impurity A NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Rupatadine EP Impurity A CAS No.: 1354055-68-7
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31

Rupatadine EP Impurity A

Article illustration



  • Product Number: R010004
  • English Name: Rupatadine EP Impurity A
  • English Alias: 3-carboxy-2-(3-((4-(8-chloro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(6H)-ylidene)piperidin-1-yl)methyl)-5-methylpyridin-1-ium-1-yl)propanoate
  • CAS Number: 1354055-68-7
  • Molecular Formula: C30H30ClN3O4
  • Molecular Weight: 532.03
  • Advantages: Rupatadine EP Impurity A is synthesized via advanced processes and multi-stage purification, featuring high purity and strong stability. Structural confirmation and content determination are conducted by precise analytical methods like NMR and HRMS, ensuring accurate chemical structure and uniform composition. It provides a reliable reference standard for drug R&D and quality control, effectively guaranteeing the accuracy and reproducibility of experimental data.
  • Applications: Mainly used for impurity analysis, quality control, and EP compliance verification of Rupatadine. In R&D, it determines impurity content and evaluates impacts on efficacy and safety; in production, as an EP reference standard, it detects impurity levels to ensure compliance with EP and other international regulations. It also applies to drug stability studies and degradation pathway analysis.
  • Background Description: As a highly effective anti-allergic drug, impurity control for Rupatadine is central to its quality system. The European Pharmacopoeia (EP) imposes strict limits on drug impurities. Rupatadine EP Impurity A, as a key impurity, may affect drug purity and efficacy, making its precise control an important step to ensure drug safety and a necessary condition for international drug registration.
  • Research Status: Current research focuses on developing highly sensitive detection methods and exploring generation mechanisms. Researchers use UPLC-MS/MS for trace analysis and optimize synthesis routes to reduce its formation during production. Meanwhile, studies on its effects on drug stability and biological activity are progressing, providing a theoretical basis for formulating reasonable impurity control strategies.
  • WhatsAPP: +86 17320513646
    E-mail: anna@molcoo.com


    NOTE!

    We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
    This product is intended for laboratory use only!

    WhatsAPP: +86 17320513646
    E-mail: anna@molcoo.com


    NEW IN STOCK!

    The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 




Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2022-04-23
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2022-04-19
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-01-24
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-05-28
INQUIRY